Hospital
Ahs Henryetta Hospital LLC
Ahs Henryetta Hospital LLC was paid $4.27M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.
33Billing provider infoAHS HENRYETTA HOSPITAL LLC
HENRYETTA, OK 74437
HENRYETTA, OK 74437
33aNPI1720053556assigned 02/23/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.27M
24GClaims47,150
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#36 of 75
Median peer was paid$3.66M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,255 | $298K | |
| 2019 | 4,779 | $454K | |
| 2020 | 4,006 | $391K | |
| 2021 | 7,867 | $689K | |
| 2022 | 14,476 | $1.17M | |
| 2023 | 9,123 | $824K | |
| 2024incomplete | 3,644 | $443K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 6,462 | 6,342 | $1.46M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 7,553 | 7,465 | $1.25M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 3,273 | 3,204 | $961K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.1% | 1,414 | 1,388 | $173K |
| 87428 | 1.9% | 2,129 | 2,106 | $81K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 1,000 | 978 | $66K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 2,782 | 2,753 | $44K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,051 | 5,000 | $41K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 855 | 775 | $38K |
| 80053 | Comprehensive metabolic panel | <1% | 2,192 | 2,125 | $20K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 112 | 111 | $19K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,807 | 3,566 | $18K |
41 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 406 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 507 | $15K |
| 87081 | <1% | 1,785 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 817 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 533 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 76 | $9K |
| 81001 | <1% | 2,349 | $7K | |
| 87400 | <1% | 243 | $6K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 54 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 114 | $4K |
| 87807 | <1% | 338 | $4K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 24 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 51 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 41 | $2K |
| 80305 | <1% | 139 | $2K | |
| 84703 | <1% | 188 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 120 | $896.07 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 137 | $705.73 |
| 80306 | <1% | 40 | $594.75 | |
| 83690 | <1% | 66 | $386.91 | |
| 83655 | <1% | 36 | $340.33 | |
| 82140 | <1% | 24 | $311.04 | |
| 80061 | Lipid panel | <1% | 25 | $309.47 |
| 84484 | <1% | 16 | $246.81 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $209.16 |
| 80143 | <1% | 12 | $198.96 | |
| 83605 | <1% | 14 | $186.42 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 25 | $175.50 |
| 82607 | <1% | 12 | $160.92 | |
| 83735 | <1% | 24 | $143.04 | |
| 85014 | <1% | 48 | $99.17 | |
| 85018 | <1% | 48 | $99.17 | |
| 82150 | <1% | 12 | $69.12 | |
| 85730 | <1% | 12 | $64.20 | |
| 84100 | <1% | 12 | $50.64 | |
| 85610 | <1% | 12 | $45.84 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 716 | $5.81 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 263 | $5.06 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12 | $3.84 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 127 | $2.34 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETROVICH, STEPHEN (SVP)
| Provider | Location | Paid |
|---|---|---|
| Lovelace Health System, LLC | Albuquerque, NM | $57.71M |
| Lovelace Health System LLC | Albuquerque, NM | $45.27M |
| Southwest Medical Associates, LLC | Albuquerque, NM | $41.40M |
| Lovelace Health System, LLC | Albuquerque, NM | $31.24M |
| Lovelace Health System LLC | Roswell, NM | $20.13M |
| Jacksonville Hospital LLC | Jacksonville, TX | $9.41M |
| Henderson Hospital, LLC | Henderson, TX | $8.52M |
| Athens Hospital, LLC | Athens, TX | $8.32M |
| Etmc Physician Group INC. | Tyler, TX | $8.03M |
| Tyler Regional Hospital LLC | Tyler, TX | $7.94M |
| Lovelace Unm Rehabilitation Hospital LLC | Albuquerque, NM | $6.30M |
| Pocatello Hospital LLC | Pocatello, ID | $6.11M |
| Jacksonville Hospital LLC | Jacksonville, TX | $5.93M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $5.61M |
| Bsa Hospital LLC | Amarillo, TX | $4.96M |
| Pittsburg Hospital LLC | Pittsburg, TX | $4.83M |
| Ahs Claremore Regional Hospital, LLC. | Claremore, OK | $4.81M |
| Pittsburg Hospital LLC | Pittsburg, TX | $3.98M |
| Topeka Hospital, LLC | Topeka, KS | $3.94M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $3.76M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.